Skip to search formSkip to main contentSkip to account menu

bemiparin

National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

Bemiparin sodium

Broader (1)

Heparin, Low-Molecular-Weight

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Influence of chemical and structural features of low molecular weight heparins (LMWHs) on skin penetration.
2013
2013
Thermosensitive macroporous cryogels functionalized with bioactive chitosan/bemiparin nanoparticles.
Thermosensitive macroporous scaffolds of poly(N-isopropylacrylamide) (polyNIPA) loaded with chitosan/bemiparin nanoparticles are… 
Review
2010
Review
2010
New frontiers with bemiparin: use in special populations.
Special populations are rarely included in conventional clinical trials and subsequently there is a lack of guidance on the… 
Review
2010
Review
2010
Bemiparin in Oncology
An association between cancer and thrombosis has been recognized since 1865. It is considered to be a two-way association; cancer… 
Review
2010
Review
2010
New Frontiers with Bemiparin
Special populations are rarely included in conventional clinical trials and subsequently there is a lack of guidance on the… 
2007
2007
[Evaluation of regular physical activity in COPD patients with an accelerometer and a questionnaire: a pilot study].
2006
2006
[Can home prophylaxis for venous thromboembolism reduce mortality rates in patients with chronic obstructive pulmonary disease?].
2001
2001
Bemiparin and Fluid Flow Modulate the Expression, Activity and Release of Tissue Factor Pathway Inhibitor in Human Endothelial Cells In Vitro
Summary We investigated the localisation, gene expression, and activity of tissue factor pathway inhibitor (TFPI) in endothelial… 
2001
2001
[Prophylactic antithrombotic therapy after orthopedic surgery with bemiparin, a second-generation low molecular weight heparin].
OBJECTIVE Bemiparin is a new second generation low molecular weight heparin with a molecular weight of 3,600 daltons and an anti… 
1998
1998
Tissue factor pathway inhibitor and anti-FXa kinetic profiles of a new low-molecular-mass heparin, Bemiparin, at therapeutic subcutaneous doses.
Low-molecular-mass heparins (LMMHs) exert an anti-FXa effect through antithrombin III (ATIII) and tissue factor pathway inhibitor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)